You cannot miss it: Pancreatic mucoepidermoid carcinoma: A case report and literature review

Medicine (Baltimore). 2018 Mar;97(11):e9990. doi: 10.1097/MD.0000000000009990.

Abstract

Rationale: Pancreatic mucoepidermoid carcinoma (MEC) is a rare disease with no more than 10 cases reported in literature. The prognosis is poor and few patients can survival more than 1 year.

Patient concerns: We presented a case of patient manifested as left upper abdominal pain. Computed tomography demonstrated a low-density shadow measuring 2.1 × 2.4 cm situated at the transition area of neck and body of the pancreas with obscure boundary and irregular enhancement. The preoperative symptoms and imaging features were unspecific.

Diagnoses: Pancreatic MEC.

Interventions: Curative surgery of distal pancreatectomy was conducted. Postoperatively, the patient subsequently underwent 8 cycles of chemotherapy using cisplatin (25 mg/m) on day 1 to day 3; and gemcitabine (1000 mg/m) on day 1 and day 8, repeated every 21 days.

Outcomes: The patient was monitored on a regular basis at our outpatient department and survived 23 months after surgery.

Lessons: Preoperative diagnosis of pancreatic MEC is difficult. Patients with pancreatic MEC may have a survival benefit from the multimodal treatment of curative surgery combined with chemotherapy.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Carcinoma, Mucoepidermoid* / pathology
  • Carcinoma, Mucoepidermoid* / physiopathology
  • Carcinoma, Mucoepidermoid* / therapy
  • Chemotherapy, Adjuvant / methods
  • Cisplatin / administration & dosage*
  • Deoxycytidine / administration & dosage
  • Deoxycytidine / analogs & derivatives*
  • Diagnosis, Differential
  • Drug Monitoring
  • Gemcitabine
  • Humans
  • Male
  • Middle Aged
  • Pancreas* / diagnostic imaging
  • Pancreas* / pathology
  • Pancreatectomy / methods*
  • Pancreatic Neoplasms* / pathology
  • Pancreatic Neoplasms* / physiopathology
  • Pancreatic Neoplasms* / therapy
  • Tomography, X-Ray Computed / methods
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Deoxycytidine
  • Cisplatin
  • Gemcitabine